Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Prostate Cancer, Prostate, genes, BRCA2 gene, BRCA2 gene mutation, prostate cancer therapy, princess margaret cancer centre, University Health Network

Prostate Cancer Team Cracks Genetic Code to Show Why Inherited Disease Can Turn Lethal

Canadian and Australian prostate cancer researchers have discovered a key piece in the genetic puzzle of why men born with a BRCA2 mutation may develop aggressive localized cancers that resist treatment and become lethal for up to 50 per cent of patients within five years.

Medicine

Channels:

Parkinson Disease, DBS, Deep Brain Stimulation

Experimental Treatment for Parkinson's Symptoms Shows Promise

More than 12 months after Parkinson's patient Bill Crawford received "DBS Plus," he can walk more easily and is back to leading services at his beloved Porter Memorial Church in Lexington, Ky.

Medicine

Channels:

Alzheimer's, Drug Discovery, Jeff Conn, Craig Lindsley, academic drug discovery , Vanderbilt Center for Neuroscience Drug Discovery , William K. Warren Foundation, Schizophrenia, Paul Newhouse, Alzheimer’s Association, Alzheimer’s Drug Discovery Foundation

Investigational New Drug for Alzheimer’s Scheduled for First Study in Humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

Medicine

Channels:

Head & Neck Cancer, Cetuximab, Chemotherapy, Radiation, personalized cancer care, Cancer, KRAS mutations, UCLA, UCLA Jonsson Comprehensive Cancer Center

UCLA-Led Study Provides Roadmap to More Personalized Cancer Treatment

Weidhaas2014250x350.png

Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.

Medicine

Channels:

ASHP, Antibiotic Stewardship , Mentorship, American Society of Health-System Pharmacists, Antibiotic Administration, MQIIP, ASHP Mentored Quality Improvement Impact Program, Debra Goff, Serena Von Ruden, George Karam, St. Francis Hospital, ASHP InterSections, Antibiotic Resistance, The Ohio State University Wexner Medical Center , Pharmacy, Pharmacist, He

Interdisciplinary Teamwork Yields Improved Antibiotic Stewardship

A hospital engaged in a quality improvement program launched by ASHP (American Society of Health-System Pharmacists) has identified weaknesses in existing antibiotic stewardship initiatives and implemented workflow changes that resulted in faster antibiotic administration. St. Francis Hospital in Federal Way, Wash., was recently featured in ASHP’s InterSections, which highlights the hospital’s team approach to improving infection treatment with IV antibiotics.

Medicine

Channels:

Antibiotics, Burn Injury, burn injury infections, multidrug-resistant, Ut Southwestern

UT Southwestern Study Identifies a Way to Prevent Burn Injury Infection – Without Antibiotics

wolf-orth-huebinger-body.jpg

A new way to fight multidrug-resistant bacteria by blinding them rather than killing them proved highly effective in a model of burn injuries, UT Southwestern Medical Center research shows.

Medicine

Science

Channels:

Cancer, Drug Design, Drug Development

Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs

Shen_authors.JPG

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.

Medicine

Channels:

Latest Analysis From Clarity Science Opera Pain Study Confirms 45% Reduction of Opioid Usage by Using Transdermal Medication

/PRNewswire/ -- Clarity, a global international scientific research company, based in Austin, Texas, announces the latest results of its IRB-approved OPERA study. OPERA (Optimizing Patient Experience and Response to Topical Analgesics) evaluates patient perceptions of pain treatment with the use of FDA-approved topical/transdermal formulations alone or in combination with neuropathic supplements via a patient-reported survey.

Life

Social and Behavioral Sciences

Channels:

A Cure for Social Anxiety Disorders

A team of doctors and psychologists examined the effects of structured talk therapy and medication on patients with social anxiety disorders. In doing so they set a new world record in effectively treating social anxiety disorder.

Medicine

Channels:

Pediatric Cancer, Cancer, personalized medicine, digital health, Oral Health, UCLA, UCLA School of Dentistry, Artificial Intelligence, drug, drug dosing, Drug Therapy

‘Turbocharged Artificial Intelligence’ Could Personalize Combination Therapy in Pediatric Leukemia

ALL_AI_figure.jpg

UCLA researchers show the potential of their digital health platform to help treat acute lymphoblastic leukemia by being able to personalize drug dosages and combinations







Chat now!